Launchpad Venture Group — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Cognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease.
BiotechDigital HealthMedical DevicesBoston, US
Dr. Lee Goldstein(Co-founder)Dr. Leo Chylack(Co-founder)Susanne Wilke(President & CEO)inCarl H. Sadowsky(Chief Medical Officer)inMike Kaswan(Chief Financial Officer)Paul Hartung(Executive Officer, Director)in
Co-investorsAEON FoundryBoston Harbor Angels
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



